Didronel and Insulin Glargine (U-300) Pens
Determining the interaction of Didronel and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: etidronate
Brand name: Didronel, Didronel IV.
Synonyms: n.a.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Didronel-Insulin glargine and lixisenatide
- Didronel-Insulin glargine and lixisenatide Subcutaneous
- Didronel-Insulin glargine, recombinant Subcutaneous
- Didronel-Insulin glulisine
- Didronel-Insulin Glulisine (Cartridges and Pens)
- Didronel-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Dienogest and estradiol
- Insulin Glargine (U-300) Pens-Diethylene Triamine Penta-Acetic Acid
- Insulin Glargine (U-300) Pens-Diethylpropion
- Insulin Glargine (U-300) Pens-Diethylpropion Controlled-Release Tablets
- Insulin Glargine (U-300) Pens-Diethylpropion Extended Release
- Insulin Glargine (U-300) Pens-Diethylpropion Hydrochloride